Acepromazine is a widely recognized veterinary medication primarily used as a tranquilizer and antiemetic agent. It is available under various trade names, including PromAce, Aceproject, and Acezine. Developed in the mid-20th century, Acepromazine is a phenothiazine derivative, a class of drugs known for their tranquilizing properties. The drug primarily targets
dopamine receptors and is employed mainly in veterinary medicine, notably for dogs, cats, horses, and occasionally other species.
Research institutions have extensively studied Acepromazine to better understand its effects, safety profile, and potential applications. In clinical practice, Acepromazine is used for multiple indications such as pre-anesthetic sedation, alleviating
anxiety, and controlling nausea and vomiting. Over the years, the drug has remained a staple in veterinary practices due to its efficacy and relative safety when used appropriately.
Acepromazine exerts its effects primarily by targeting dopamine receptors in the brain, particularly the D2 subtype. This action results in a reduction of dopamine's stimulant effects, leading to sedation and tranquilization. Additionally, Acepromazine has
alpha-adrenergic receptor antagonistic properties, which contribute to its hypotensive effects by causing vasodilation. This multi-receptor targeting results in a calming effect on the animal, making it easier to manage during stressful situations such as surgery or transport.
The drug is also known to have antiemetic properties, which are believed to result from its dopaminergic antagonism in the chemoreceptor trigger zone (CTZ) of the brain. This makes Acepromazine particularly useful in preventing nausea and vomiting, a common concern in pre- and post-operative care.
Acepromazine can be administered in various forms, including oral tablets, injectable solutions, and sometimes as part of a compounded formulation. The route of administration often depends on the specific needs of the animal and the situation at hand.
For oral administration, the onset of action generally occurs within 30-60 minutes, with the effects lasting anywhere from 6-8 hours. Injectable forms of Acepromazine, often administered intramuscularly or intravenously, typically have a quicker onset, usually within 15-30 minutes, and can last up to 12 hours. It is crucial to follow the veterinarian's dosage recommendations closely, as the dosage can vary widely based on the species, size, and condition of the animal.
Despite its benefits, Acepromazine is not without potential side effects. Common side effects include
hypotension,
bradycardia, and
ataxia. Gastrointestinal symptoms such as
loss of appetite,
vomiting, and
diarrhea may also occur. More severe adverse reactions, although rare, can include
respiratory depression and
profound sedation. Due to these potential effects, careful monitoring is essential, especially during initial dosing or when adjusting the dosage.
Contraindications for Acepromazine use include animals with pre-existing conditions such as
cardiovascular disease, liver dysfunction, or a history of
seizures. The drug should also be used cautiously in geriatric, debilitated, or extremely young animals. Pregnant or lactating animals should only receive Acepromazine if deemed absolutely necessary by a veterinarian.
Several drugs can interact with Acepromazine, potentially altering its efficacy or increasing the risk of adverse effects. For example, combining Acepromazine with other central nervous system depressants such as barbiturates, benzodiazepines, or opioids can amplify sedative effects, leading to excessive sedation or respiratory depression.
Moreover, drugs that affect liver enzyme activity may alter the metabolism of Acepromazine, necessitating dosage adjustments. Medications that have hypotensive effects, including certain diuretics and antihypertensives, can further reduce blood pressure when used concurrently with Acepromazine.
In summary, Acepromazine is a valuable tool in veterinary medicine, offering multiple benefits from sedation to antiemetic effects. Its mechanism of action involves dopamine receptor antagonism and alpha-adrenergic receptor blockade, leading to effective tranquilization and
nausea control. Administered through various routes depending on the clinical scenario, it requires careful attention to dosage and monitoring due to potential side effects and contraindications. Additionally, veterinarians must be aware of drug interactions that could impact the safety and effectiveness of Acepromazine. When used judiciously, Acepromazine remains an essential component of the veterinary pharmacological arsenal.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


